Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain.

Ortuzar, ArianaFox, María LauraVera, Juan AntonioLorenzo Vizcaya, ÁlvaroMarín Sánchez, AlbertoLlopis Calatayud, InmaculadaCarbonell, SaraÁlvarez-Larrán, AlbertoMata Serna, RaquelMarco Buades, Josefa EQuiroz Cervantes, KeinaMartínez Hellín, ÁngelaBlum Domínguez, AlejandraCaballero Navarro, GonzaloCáceres Sansaloni, AmparoGuerrero Fernández, LucíaMuñoz Linares, CristinaGasior Kabat, MercedesPérez López, RaúlFernández Rodríguez, ÁngelesMartínez Bilbao, CristinaCobo Rodríguez, María TeresaDíaz, ÁlvaroDurán, M AntoniaSantaliestra Tomas, MartaGarcía-Gutierrez, ValentínMagro Mazo, ElenaHernández-Boluda, Juan CarlosSegura, AdriánRaya, José MaríaNavas Elorza, BegoñaOsorio, Santiago2023-05-032023-05-032022-11-23http://hdl.handle.net/10668/19742The SARS-CoV-2 pandemic has favored the expansion of telemedicine. Philadelphia-negative chronic myeloproliferative neoplasms (Ph-MPN) might be good candidates for virtual follow-up. In this study, we aimed to analyze the follow-up of patients with Ph-MPN in Spain during COVID-19, its effectiveness, and acceptance among patients. We present a multicenter retrospective study from 30 centers. Five hundred forty-one patients were included with a median age of 67 years (yr). With a median follow-up of 19 months, 4410 appointments were recorded. The median of visits per patient was 7 and median periodicity was 2.7 months; significantly more visits and a higher frequency of them were registered in myelofibrosis (MF) patients. 60.1% of visits were in-person, 39.5% were by telephone, and 0.3% were videocall visits, with a predominance of telephone visits for essential thrombocythemia (ET) and polycythemia vera (PV) patients over MF, as well as for younger patients (enCOVID-19Follow-upPatient satisfactionPh-MPNSpainTelemedicineHumansAgedPandemicsRetrospective StudiesPatient SatisfactionSpainCOVID-19SARS-CoV-2Myeloproliferative DisordersPolycythemia VeraPrimary MyelofibrosisThrombocythemia, EssentialPhiladelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain.research article36422672open access10.1007/s00277-022-05044-x1432-0584PMC9686214https://link.springer.com/content/pdf/10.1007/s00277-022-05044-x.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686214/pdf